Tags
Results for: Johnstone Lab
-
Article ItemCategory: research Virginia Tech researcher earns fellowship to explore how obesity increases the risk for heart disease , article
Mark Renton, a postdoctoral associate with the Fralin Biomedical Research Institute at VTC, will use the American Heart Association fellowship to investigate how the pannexin-1 protein regulates blood flow in an obesity-induced heart condition.
Date: Mar 20, 2025 - -
Video ItemCategory: research Postdoctoral Excellence Awards celebrate promising scientific research , video
The Fralin Biomedical Research Institute Postdoctoral Excellence Awards, established through the generosity of Mary Denton Roberts and David Lyerly, recognize exceptional research potential and professional development. The most recent recipients are Ignacio Aiello, Xiaobo Wu, and Mark Renton. The awards recognize the potential for impactful individual scientific contributions. Recipients are selected based on the likelihood that their research proposal will lead to novel contributions as well as their mentors' ability to enhance their professional development. Roberts taught microbiology and immunology at Radford University from 1980 to 2006. Lyerly is a co-founder and chief science officer of the Blacksburg-based medical diagnostics company TechLab Inc. He and colleague Tracy Wilkins founded the company in 1989, based on discoveries from their research on Clostridium difficile, the major cause of hospital-acquired diarrhea and colitis.
Date: Mar 11, 2025 - -
Article ItemFralin Biomedical Research Institute scientist to co-chair international forum on gap junctions , article
Co-chairs James Smyth and Silvia Penuela are bringing scientists from across the globe to Arlington to share findings in a rapidly developing field whose insights point to novel therapeutic opportunities in a wide range of disorders and complex diseases.
Date: May 24, 2024 - -
Article ItemCategory: research From healthy development to cancer treatments, Fralin Biomedical Research Institute scientists aim for impact , article
New Seale Innovation Fund projects fuel a broad spectrum of research focused on cardiovascular disease, diabetes, cancer, stress, brain development, and more.
Date: Jan 29, 2024 - -
Article ItemCategory: research National Institutes of Health award propels translational biology, medicine, and health student on path to discovery , article
Meghan Sedovy, a doctoral candidate and graduate research assistant in the Johnstone Lab at the Fralin Biomedical Research Institute at VTC, was awarded a Ruth L. Kirschstein Predoctoral Individual National Research Service Award to further her study of wound healing in arteries after heart surgery.
Date: Jan 23, 2024 - -
Article ItemCategory: research Researchers find that using patients’ own blood rather than saline helps preserve veins in coronary bypass grafts , article
A Fralin Biomedical Research Institute cardiovascular scientist and a Carilion Clinic surgeon team up for a clinical trial with the potential to improve health outcomes.
Date: Jan 16, 2024 - -
Video ItemCategory: impact Thank you from the Fralin Biomedical Research Institute - #VTGivingDay , video
On behalf of the Fralin Biomedical Research Institute at VTC, thank you very, very much for your generosity on Giving Day. Every day your support helps us to bring to the public health the advances and innovation of our faculty, students and staff. Thank you!
Date: Feb 17, 2023 - -
Article ItemCategory: research Philanthropy supports pilot projects to take on health challenges such as heart disease, diabetes, cancer, stress, and chronic pain , article
Giving Day contributions to the Fralin Biomedical Research Institute at VTC have double the impact, unlocking $20,000 to the Seale Innovation Fund to accelerate innovation
Date: Feb 15, 2023 - -
Article ItemCategory: research Three translational biology, medicine, and health graduate students awarded American Heart Association fellowships , article
The awards are intended to enhance the research and clinical training of promising students seeking careers as scientists, physician-scientists, or clinician scientists interested in improving global cardiovascular, cerebrovascular, and brain health.
Date: Jan 11, 2023 - -
Article ItemCategory: research Fralin Biomedical Research Institute at VTC Center for Vascular and Heart Research holds retreat to catalyze collaboration , article
The daylong retreat at The Hotel Roanoke & Conference Center and on the research institute campus included presentations by research teams about their lab’s key techniques, competencies, and equipment.
Date: Jul 21, 2022 - -
Video ItemCategory: research Meet Scott Johnstone, a new cardiovascular investigator at the Fralin Biomedical Research Institute , video
As we continue our series focused on the newest faculty members working in our brand new, $90-million biomedical research addition facility, it's our pleasure to introduce Scott Johnstone – a new principal investigator who is working to understand how healthy blood vessels are altered in disease. Johnstone's lab also focuses on defining pathways to therapeutically target vascular disease.
Date: Nov 05, 2021 - -
Article ItemCategory: research Applications are open for the 2021 Virginia Tech Health Sciences and Technology Commercialization Fellows Program , article
Applications for the new program cohort are due online by 5 p.m. on March 12. Graduate students, postdoctoral researchers, and research assistants and associates from across Virginia Tech who conduct health sciences and technology-related research are eligible.
Date: Mar 03, 2021 - -
Video ItemCategory: research Meet our Scientists: Dr. Farris, Dr. Johnstone, Dr. LaMantia, Dr. Montague, Dr. Shin, and Dr. Munson , video
<div>The Fralin Biomedical Research Institute at VTC’s researchers have diverse backgrounds. Learn more about their research, hobbies, backgrounds, and why they became scientists in our 2021 weekly video series.</div>
Date: Jan 28, 2021 - -
Article ItemCategory: research New Fralin Biomedical Research Institute at VTC scientist pursues heart disease treatments , article
Scott Johnstone’s team is designing drugs that interrupt protein interactions to curb pathological cell division.
Date: Nov 11, 2020 -